| Plenary Session Eng |
09:00-10:00, Crystal Ballroom |
| 1) Laparoscopy-Assisted versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: Results from a Randomized Phase II Multicenter Clinical Trial (COACT 1001)
|
| Young Kyu Park (Chonnam National University Hwasun Hospital)
|
| 2) Osimertinib in patients with T790M positive advanced non-small cell lung cancer (NSCLC): Korean subgroup analysis from pooled phase II data
|
| Myung-Ju Ahn (Samsung Medical Center |
| 3) Intra-individual genomic heterogeneity of serous adenocarcinoma of ovary and clinical utility of ascitic cancer cells for mutation profiling
|
| Youn Jin Choi (The Catholic University of Korea College of Medicine) |
|
| Symposium 12 Eng |
09:00-10:40, Sapphire Ballroom B |
| Joint Symposium (Korean Cancer Association & Inha MRC) |
|
Tumor microenvironment |
| 1) Metabolic heterogeneity of non-small cell lung cancer; GLUT 1 as a novel diagnostic and therapeutic target for squamous lung cancer |
| Jung-whan Kim (The University of Texas at Dallas, USA) |
| 2) Tumor dormancy under hypoxic conditions |
| Masahiro Inoue (Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan) |
| 3) Intravital microscopy technique for cancer research |
| Pilhan Kim (KAIST) |
| 4) Biomarker discovery and development ; Experience in cerebrospinal fluid biomarkers of Alzheimer's disease |
| Ju-Hee Kang (Inha University School of Medicine) |
|
| Plenary Lecture 3 Eng |
10:20-10:50, Crystal Ballroom |
| Inflammatory microenvironment as a target for cancer prevention and therapy |
| Young-Joon Surh, Ph.D. (Seoul National University College of Pharmacy) |
|
| Plenary Lecture 4 Eng |
10:50-11:40, Crystal Ballroom |
| Induction of cancer stemness and drug resistance by EGFR inhibitors and cellular stress |
| David A. Cheresh, Ph.D. (Moores UCSD Cancer Center & UC San Diego School of Medicine, USA) |
|
| Symposium 13 Eng |
13:40-15:20, Crystal Ballroom A |
| Joint Symposium (Korean Cancer Association & Beijing Medical Association) |
|
|
| 1) Cancer Burden in China |
| Jie Ma (Secretary of Cancer Association of Beijing Medical Association, China) |
| 2) Prostate Cancer in China |
| Zheng Zhang (Vice Chair of Youth Cancer Association of Beijing Medical Association, China) |
| 3) Building the infrastructure for precision oncology in Korea |
| Tae-You Kim (Seoul National University College of Medicine) |
| 4) The Effect of government surgical quality assessment service on colorectal cancer surgery in Korea |
| In Kyu Lee (The Catholic University of Korea College of Medicine) |
|
| Symposium 14 Eng |
13:40-15:20, Crystal Ballroom B |
|
Cancer-Nano precision theragnostics
|
| 1) Novel sensing approaches for liquid biopsy with multiplexing and precision
|
| Sehyun Shin (Korea University College of Engineering)
|
| 2) Liquid Biopsy Usage in Clinical Oncology |
| Yeul Hong Kim (Korea University College of Medicine)
|
| 3) Molecular subtype of gastric cancer and their biological characteristics |
| Jae Ho Chung (Yonsei University College of Medicine)
|
| 4) Multiplexed, robust LSPR based miRNA measurement with highly controlled Top-down nanosystems |
| Jungsub Wi (Korea Research Institute of Standards and Science)
|
|
| Symposium 15 Eng |
13:40-15:20, Crystal Ballroom C |
|
Cancer immunology |
| 1) Harnessing immune system to fight against cancer |
| Sang-We Kim (Asan Medical Center) |
| 2) Toward the identification of determinants of cancer immune responsiveness |
| Kyong Hwa Park (Korea University College of Medicine) |
| 3) Converting non-immunogenic tumor to immunogenic tumor: resistance and combination |
| Bhumsuk Keam (Seoul National University College of Medicine) |
|
| Symposium 16 Eng |
13:40-15:20, Sapphire Ballroom A |
|
Autophagy regulation in the development and treatment of cancer
|
| 1) Autophagic proteolysis by the N-end rule pathway |
| Yong Tae Kwon (Seoul National University College of Medicine)
|
| 2) ER stress to autophagy as a promising druggable target in ovarian cancer |
| Yong Sang Song (Seoul National University College of Medicine) |
| 3) Metabolism and autophagy: pathways for potential cancer therapeutics |
| Heesun Cheong (National Cancer Center) |
| 4) Molecular anatomy of RavZ, LC3-deconjugating enzyme |
| Hyun Kyu Song (Korea University Division of Life Sciences) |
|
| Symposium 17 Eng |
13:40-15:20, Sapphire Ballroom B |
|
Exosome
|
| 1) Exosomes: from Basics to Clinic |
| Yong Song Gho (Pohang University of Science and Technology) |
| 2) Molecualr characterization of extracellular vesicles by proteomics and lipidomics based on mass spectrometry |
| Kwang Pyo Kim (Kyung Hee University College of Applied Science) |
| 3) In vivo radionuclide imaging of exosome-mimetic nanovesicle |
| Do Won Hwang (Seoul National University College of Medicine) |
|
| Symposium 18 Eng |
15:40-17:20, Crystal Ballroom A |
|
Current status and future perspectives of genomic diagnosis in cancer
|
| 1) Current updates and clinical roles of cancer genomic diagnosis in USA |
Jin-Soo Kim (Seoul National University Boramae Medical Center)
|
| 2) Efforts to push cancer genomics to cancer precision medicine of lung cancer |
| Yong Hou (Beijing Genomics Institute, China) |
| 3) Current understanding of ethnic differences in mutation profiles for the clinical application of cancer genomics data in Korea
|
| Hark Kyun Kim (National Cancer Center)
|
|
| Symposium 19 Eng |
15:40-17:20, Crystal Ballroom B |
|
Oncology leadership in Asia |
| 1) Kazuhiro Yoshida (Gifu University, Graduate School of Medicine, Japan) |
| 2) Hideo Baba (Graduate School of Medical Sciences Kumamoto University, Japan) |
| 3) Marie Cherry Lynn Samson-Fernando (Manila Doctors Hospital, Philippines) |
| 4) Sanjeev Misra (All India Institute of Medical Sciences, India) |
| 5) Zeba Aziz (Hameed Latif Hospital, Pakistan) |
| 6) Rainy Umbas (Faculty of Medicine University of Indonesia, Indonesia) |
| 7) Yogendra P Singh (Tribhuvan University Teaching Hospital, Nepal) |
| 8) Tony Shu Kam MOK (The Chinese University of Hong Kong, Hong Kong) |
| 9) Han-Kwang Yang (Seoul National University College of Medicine) |
|
| Symposium 20 Eng |
15:40-17:20, Crystal Ballroom C |
| Joint Symposium (Korean Cancer Association & The Korean Gastric Cancer Association) |
|
Treatment strategies in stage Ⅳ gastric cancer |
| 1) Lessons from REGATTA trial |
Do Joong Park (Seoul National University Bundang Hospital) |
| 2) Conversion surgery for stage IV gastric cancer patients |
| Oh Kyoung Kwon (Kyungpook National University School of Medicine)
|
| 3) What is optimal chemotherapy in different situation with stage Ⅳ gastric cancer patient? |
| Sook Ryun Park (Asan Medical Center) |
| 4) Diagnostic laparoscopy for stage IV gastric cancer |
| Kyo Young Song (The Catholic University of Korea College of Medicine) |
|
| Symposium 21 |
15:40-17:20, Sapphire Ballroom B |
| Joint Symposium (Korean Cancer Association & Korean Society of Gynecologic Oncology) |
| I. Innovative clinical trial design for ovarian cancer |
| 1) Current evidence and role of neoadjuvant chemotherapy in advanced ovarian cancer |
| Myong Cheol Lim (National Cancer Center) |
| 2) Lessons from breast cancer: How can we incorporate translational research into neoadjuvant treatment followed by surgery setting? |
| Joo Hyuk Sohn (Yonsei University College of Medicine) |
| 3) Innovative neoadjuvant treatment clinical trial design for advanced ovarian cancer |
| Chel Hun Choi (Samsung Medical Center) |
|
| II. Future therapy for gynecological cancer |
| 1) GOG 240 and beyond: novel therapies in the treatment of cervical cancer |
| Jong-Min Lee (Kyung Hee University School of Medicine) |
| 2) Controversies about the role of sentinel node sampling in endometrial cancer |
| Taek Sang Lee (Seoul National University Boramae Medical Center)
|
| 3) Molecular pathogenesis and appropriate target therapies for endometrial cancer |
| Shin-Wha Lee (Asan Medical Center) |
|
| Satellite Symposium 2 Eng |
11:50-12:50, Crystal Ballroom A |
| A new perspective in the treatment of NSCLC : Targeting EGFR (by Roche) |
| Roman Perez-Soler (Montefiore Medical Park, USA) |
|
|
|
| Satellite Symposium 3 Eng |
11:50-12:50, Crystal Ballroom C |
| RADIANT-4: Efficacy and safety of everolimus in advanced, nonfunctional neuroendocrine tumors (NET) of the lung or gastrointestinal (GI) tract (by Novartis) |
| Do-Youn Oh (Seoul National University College of Medicine) |
|
| Special Symposium |
09:00~11:00, Sapphire Ballroom A |
| 면역항암제 국내 도입과 과제 |
| 09:00 - 09:05 |
오프닝 |
좌장 김흥태 교수(국립암센터) |
| 1부 주제 발표: 면역항암제로 인한 암 치료 환경의 변화 | 09:05 - 09:50 |
| 09:05 - 09:25 |
[발표 1] 암 치료 패러다임 변화의 중심, 면역항암제 |
대한암학회 이대호 교수 (서울아산병원) |
| 09:20 - 09:35 |
[발표 2] 면역항암제로 인한 삶의 변화 |
면역항암제 투여 환자 |
| 09:35 - 09:50 |
[발표 3] 암 보장성 강화를 위한 정부의 성과 |
보건복지부 고형우 과장 |
| 2부 전체 토론: 면역항암제 도입 과제 및 해결 방안 | 09:50 - 10:40 |
| 09:50 - 10:40 |
기존 항암제 도입 케이스로 살펴본 면역항암제의 도입 한계 |
대한암학회 학술이사
김열홍 교수 (고대안암병원) |
| 면역항암제 도입과 보험급여 정책 개선의 필요성 |
이의경 교수 (성균관대학교) |
| 국내 급여평가 시스템과 면역항암제 도입 방향 |
건강보험심사평가원
조정숙 실장 |
| 면역항암제로 인한 국내 보건환경 변화 흐름의 방향 |
조선일보 김철중 의학전문기자 |
| 10:40 - 11:00 |
전체토론 및 질의응답 |
전체 |
|
| Oral Presentation 6 |
13:40-15:20, Pine Room |
|
| Oral Presentation 7 |
15:40-17:20, Pine Room |
|
| Oral Presentation 8 |
15:40-17:20, Sapphire Ballroom A |
|
| International Session 5 (Oral)Eng |
13:40-15:20, Sapphire Ballroom C |
|
| International Session 6 (Oral)Eng |
15:40-17:20, Sapphire Ballroom C |
|
| Poster Presentation |
09:00-17:00, Emerald Room |
|
|
